Infinity Pharmaceuticals Stock (NASDAQ:INFI)


ForecastOwnershipChart

Previous Close

$0.02

52W Range

$0.01 - $1.30

50D Avg

$0.09

200D Avg

$0.26

Market Cap

$726.09K

Avg Vol (3M)

$3.98M

Beta

1.38

Div Yield

-

INFI Company Profile


Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of metastatic triple negative breast cancer and urothelial cancer; and Phase 1/1b clinical trials for the treatment of solid tumors. The company has strategic alliances with Intellikine, Inc. to discover, develop, and commercialize pharmaceutical products targeting the delta and/or gamma isoforms of PI3K; Verastem, Inc. to research, develop, commercialize, and manufacture duvelisib and products containing duvelisib; and PellePharm, Inc. to develop and commercialize rights to its hedgehog inhibitor program, IPI-926, a clinical-stage product candidate, as well as collaboration agreements with Arcus Biosciences, Inc., F. Hoffmann-La Roche Ltd., and Bristol Myers Squibb Company. Infinity Pharmaceuticals, Inc. was incorporated in 1995 and is headquartered in Cambridge, Massachusetts.

Show More

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

30

IPO Date

Jul 28, 2000

Website

INFI Performance


Latest Earnings Call Transcripts


Q3 22Nov 14, 22 | 11:24 AM
Q2 22Aug 09, 22 | 11:03 PM
Q1 22May 03, 22 | 11:16 PM

Peer Comparison


TickerCompany
NUVBNuvation Bio Inc.
NXTCNextCure, Inc.
EWTXEdgewise Therapeutics, Inc.
ERASErasca, Inc.
ADTXAditxt, Inc.
CTMXCytomX Therapeutics, Inc.
REVBRevelation Biosciences, Inc.
GBIOGeneration Bio Co.
SQZSQZ Biotechnologies Company
DRMADermata Therapeutics, Inc.
KRONKronos Bio, Inc.
CCCCC4 Therapeutics, Inc.
ELDNEledon Pharmaceuticals, Inc.
ASMBAssembly Biosciences, Inc.
NRBONeuroBo Pharmaceuticals, Inc.
TARAProtara Therapeutics, Inc.
UNCYUnicycive Therapeutics, Inc.
TRVITrevi Therapeutics, Inc.
NLTXNeurogene Inc.
CMRXChimerix, Inc.
LYRALyra Therapeutics, Inc.
TILInstil Bio, Inc.